ELEMENT AND METHOD FOR THE DETERMINATION OF CREATININE OR CREATINE

Abstract: An analytical element can be used for the determination of either creatinine or creatine or both. The element contains creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase, and an imidazole leuco dye which is capable of providing a detectable dye in the presence of hydrogen peroxide and a peroxidative substance. The creatine amidinohydrolase is present in a manner such that it is substantially inert to the leuco dye. The creatinine amidohydrolase is present in a rate limiting amount. By measuring the amount of dye formation at particular times during the assay, either or both of the analytes can be determined with the same element.

Description: The present invention relates to clinical chemistry. In particular, it relates to an analytical element and method for the determination of either creatinine or creatine in aqueous liquids, for example biological fluids. The determination of the intermediate and end products of protein metabolism is important in clinical chemistry, and particularly in the diagnosis of kidney function. The products of this metabolism include creatinine and creatine. Creatinine is a product of the endogenous metabolism of muscle. The amount of creatinine in the urine reflects total muscle mass and the degree of muscle activity. The amount of creatinine in a person's urine is generally constant, varying little from day to day. Urinary creatine is elevated in the early stages of muscular dystrophy, when muscle destruction is occurring rapidly, and in any wasting disease involving increased tissue catabolism. It is elevated during severe and strenuous muscular activity and in hyperthyroidism. Urinary creatinine is decreased during the later stages of muscular dystrophy and whenever renal function is impaired. Urinary creatine increases in the same disease states that produce an increase in urinary creatinine. Methods for the determination of creatinine have been frequently described. Early tests were based on the nonenzymatic Jaffe reaction which involves the formation of an orange-red color with an alkaline picrate solution. This method, however, is hot specific for creatinine since many substances similar to creatinine also react with alkaline picrate. Enzymatic assays for creatinine have been developed using enzymes specific for creatinine and creatine, respectively, and the following reaction sequence: (1) creatinine + water ⇄ creatine (2) creatine + water → urea + sarcosine The first reaction is catalyzed by creatinine amidohydrolase whereas the second one is catalyzed by creatine amidinohydrolase. An assay for creatinine is described in U.S. Patent 4,215,197 wherein the enzymes noted above are used in combination with sarcosine oxidase and a tetrazolium indicator. The assay can be performed in solution or with a dry device into which the reagents have been imbibed. Only creatinine can be measured when all of the reagents are included in the analytical composition. As shown in Example I (Col. 5, line 64 to Col. 6, line 24) of this reference, the assay requires a long incubation period (that is, up to sixty minutes), and a blanking step to subtract out background resulting from the reagents used and endogenous creatine. The sensitivity is allegedly increased by including formaldehyde dehydrogenase, diaphorase and NAD in the composition. This significantly complicates the assay with additional reagents and enzymatic reactions. Creatine or sarcosine can be measured with the assay if the appropriate enzymes are omitted. But this requires separate compositions or test devices for determining each analyte. It would be desirable to have a relatively simple, automated dry assay that is equally useful for either creatinine or creatine determination, which is highly sensitive and rapid and requires no blanking step. The problems encountered with known assays are overcome with an analytical element for the determination of either creatinine or creatine comprising an absorbent carrier material containing creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase, the element characterized as further comprising an imidazole leuco dye which is capable of providing a detectable dye in the presence of hydrogen peroxide and a peroxidative substance, the creatine amidinohydrolase being present in a manner such that it is substantially inert to the leuco dye, and the creatinine amidohydrolase being present in a rate limiting amount. In a preferred embodiment, a multilayer analytical element for the determination of either creatinine or creatine comprises a support having thereon, in order, a first reagent layer containing sarcosine oxidase, creatinine amidohydrolase and a peroxidative substance, a second reagent layer containing creatine amidinohydrolase, and a porous spreading layer, the element characterized wherein the creatinine amidohydrolase is present in a rate limiting amount and the first reagent layer further comprises an imidazole leuco dye which is capable of providing a detectable dye in the presence of the peroxidative substance and hydrogen peroxide. A method for the determination of either creatinine or creatine comprises the steps of: A. in the presence of a peroxidative substance and a substance capable of providing a detectable dye in the presence of the peroxidative substance and hydrogen peroxide, contacting a sample of a liquid suspected of containing either creatinine or creatine with an analytical element comprising an absorbent carrier material containing amidohydrolase, creatine amidinohydrolase and sarcosine oxidase, and B. determining the detectable dye formed as a result of the presence of either creatinine or creatine, the method characterized wherein the element further comprises an imidazole leuco dye as the detectable dye providing substance, the creatine amidinohydrolase is present in a manner such that is substantially inert to the leuco dye, and the creatinine amidohydrolase is present in a rate limiting amount. The present invention provides a relatively simple, automated means to rapidly and economically measure either creatinine or creatine or both with the same analytical element. Separate analytical compositions or elements are therefore not needed for the different analytes. The assay of this invention is rapid, allowing measurement of either analyte within, for example, 5 minutes. It is also possible to avoid tedious blanking steps with the present invention. The complex equipment used for solution assays known in the art is therefore avoided with the present invention. These advantages are possible with the present invention because it is a kinetic assay for creatinine performed with the analytical element described herein. This element contains creatinine amidohydrolase and creatine amidinohydrolase which promote the two enzymatic reactions (1) and (2) noted above. However, the creatinine amidohydrolase is present in a rate limiting amount so that once endogenous creatine has completely reacted, the rate of dye formation is due totally to the presence of creatinine. However, creatine can also be accurately measured with this element by measuring the amount of dye formation early in the assay. Background is minimized by putting the reagents into the element in such a manner that they do not interfere with each other. In particular, the creatine amidinohydrolase is present in a manner such that it is substantially inert to the leuco dye. FIG. 1 is a graphical plot of creatine determined by a reference method vs. creatine determined by the method of this invention. FIG. 2 is a graphical plot of creatinine determined by a reference method vs. creatinine determined by the method of this invention. The present invention relates to the determination (qualitative or quantitative measurement) of either creatinine or creatine in aqeuous liquids. In particular, the invention can be used to assay biological fluids of animals and humans. Such fluids include, but are not limited to, whole blood, plasma, sera, lymph, bile, urine, spinal fluid, sputum, perspiration and the like as well as stool secretions. It is also possible to assay fluid preparations of human or animal tissue such as skeletal muscle, heart, kidney, lungs, brains, bone marrow, skin and the like. Preferably, human serum or urine is assayed with this invention. The method of this invention is practiced using a dry analytical element. The simplest element can be composed of an absorbent carrier material, for example a thin sheet of a self-supporting absorbent or bibulous material, such as filter paper or strips, which contains the reagents needed for the assay. The element can be divided into two or more discrete zones with different reagents incorporated into individual zones of the carrier material. Such elements are known in the art as test strips, diagnostic elements, dip sticks, diagnostic agents and the like. Useful absorbent carrier materials are insoluble and maintain their structural integrity when exposed to water or biological fluids such as urine or serum. Useful elements can be prepared from paper, porous particulate structures, porous polymeric films, cellulose, glass fibers, woven and nonwoven fabrics (synthetic and nonsynthetic). Useful materials and procedures for making such elements are well known in the art. Preferably, the dry analytical element of this invention has a porous spreading zone. This zone can be self-supporting (that is, composed of a material rigid enough to maintain its integrity), but preferably it is carried on a separate nonporous support. Such a support can be any suitable dimensionally stable, and preferably, nonporous and transparent (that is, radiation transmissive) material which transmits electromagnetic radiation of a wavelength between 200 and 900 nm. A support of choice for a particular element should be compatible with the intended mode of detection (transmission or reflectance spectroscopy). Useful supports can be prepared from paper, metal foils, polystyrene, polyesters [e.g. poly(ethylene terephthalate)], polycarbonates or cellulose esters. The porous spreading zone can be prepared from any suitable fibrous or non-fibrous material or mixtures of either or both as described in U. S. Patents 4,292,272, 3,992,158, 4,258,001 and 4,430,436 and Japanese Patent Publication 57(1982)-101760. It is desirable that the spreading zone be isotropically porous, meaning that the porosity is the same in each direction in the zone as caused by interconnected spaces or pores between particles, fibers or polymeric strands. The elements can have two or more discrete zones, either in the same layer or superimposed, at least one of which is preferably a porous spreading zone. The other zones can be reagent zones or registration zones as those zones are known in the art, additional spreading zones, radiation-blocking or filter zones, subbing zones or barrier zones. The zones are generally in fluid contact with each other, meaning that generally fluids, reagents and reaction products (for example, color dyes) can pass or be transported between superposed regions of adjacent zones. Preferably, the zones are separately coated and superposed layers. The assay of this invention is accomplished with the following sequence of reactions (1)-(4): (1) creatinine + water ⇄ creatine (2) creatine + water → urea + sarcosine (3) sarcosine + oxygen + water → glycine + formaldehyde + hydrogen peroxide (4) hydrogen peroxide + leuco dye → detectable dye. These reactions are catalyzed by creatinine amidohydrolase, creatine amidinohydrolase, sarcosine oxidase and a peroxidative substance, respectfully. The enzymes described herein can be used in the practice of this invention in pure form, as fermentation solutions or as impure extracts of the enzymes, individually or collectively. Creatinine amidohydrolase and creatine amidinohydrolase can be obtained commercially from a number of sources. Several species of each enzyme, isolated from various microbial sources are known in the art. Creatinine amidohydrolase having a pH optimum of 6.5 at 37°C and creatine amidinohydrolase having a pH optimum of 7.7 at 37°C, both obtained from a strain of Flavobacterium and described in U.S. Patent 4,039,384, are preferred. Sarcosine oxidase can also be obtained commercially from a number of sources. This enzyme is described, for example, in U.S. Patent 4,216,292 and Japanese Patent Publications 56(1981)-092,790 and 57(1982)-036,985. Sarcosine oxidase from any source is useful in the practice of this invention. Peroxidative substances useful in this invention include peroxidase. A peroxidase is an enzyme which will catalyze a reaction wherein hydrogen peroxide oxidizes another substance. The peroxidases are generally conjugated proteins containing iron porphyrin. Peroxidase occurs in horseradish, potatoes, fig tree sap and turnips, milk and white blood cells. It also occurs in microorganisms and can be produced by fermentation. Certain synthetic peroxidases are also known. Peroxidase is a preferred peroxidative substance, but other substances which are not enzymes are also useful. Many of these are commercially available. The leuco dyes useful in this invention are imidazole leuco dyes which are generally colorless in the leuco form, but which can be oxidized to a detectable colored dye in the presence of hydrogen peroxide and a peroxidative substance. Useful leuco dyes include di- and triarylimidazoles such as those described in U.S. Patent 4,089,747, E.P. Publication 122,641 and Japanese Patent Publication 58(1983)-045,557. Particularly useful imidazole leuco dyes are the triarylimidazoles described in U.S. Patent 4,089,747, including 2-(3,5-­ dimethoxy-4-hydroxyphenyl)-4,5-bis(4-dimethyl­ aminophenyl)imidazole, 2-(4-hydroxy-3-methoxy­ phenyl)-4,5-bi( p -dimethylaminophenyl)-1H-imidazole, 2-(3-ethoxy-4-hydroxyphenyl-4,5bis( p -dimethylamino­ phenyl)-1H-imidazole, 2-(4-hydroxy-3,5-dimethoxy­ phenyl)-4-[4-(dimethylamino)-phenyl]-5-(2-furyl)-­ imidazole, 2-(4-hydroxy-3,5-dimethoxyphenyl)-4,5-­ di(2-furyl)imidazole, 2-(3,5-dimethoxy-4-hydoxy­ phenyl)-4-[4-(dimethylamino)phenyl]-5-phenethyl­ imidazole and 2-(3,5-dimethoxy-4-hydroxyphenyl)-­ 4-[4-(dimethylamino)phenyl]-5-benzylimidazole. The elements of this invention can also contain one or more other addenda commonly included in the elements for various manufacturing or operational advantages. Such addenda include surfactants, ion chelating agents, buffers, solvents, hardeners, antioxidants and coupler solvents. It is critical that the creatinine amidohydrolase be present in the element in a rate limiting amount. This means that the amount of this enzyme in relation to the amount of creatine amidinohydrolase is such that the forward direction of reaction (1) noted above is rate controlling. The specific amount of creatinine amidohydrolase can be readily determined by a skilled clinical chemist. Generally, the amount is less than 2500, and preferably from 100 to 1000, I.U./m². Creatine amidinohydrolase can be present in any amount as long as it is not a rate limiting amount. In other words, reaction (2), noted above, is not to be controlling in the assay. The specific amount of this enzyme can be readily determined by a skilled clinical chemist. Another way of stating the amounts of creatine amidinohydrolase and creatinine amidohydrolase is that they are generally present in a coverage ratio of activity (I.U. per m²) of at least 50:1. Preferably, this ratio is at least 100:1. As used in the context of this disclosure and the claims, I.U. represents the International Unit for enzyme activity defined as one I.U. being the amount of enzyme activity required to catalyze the conversion of 1 micromole of substrate per minute under standard pH and temperature conditions for the enzyme. For the preferred enzyme preparations used in this invention, these standard conditions are 37° C and pH 7.5 for creatinine amidohydrolase, 37° C and pH 7.5 for creatine amidinohydrolase, 37° C and pH 7.5 for sarcosine oxidase and 37° C and pH 7.5 for peroxidase. The other reagents useful in the assay are present in suitable amounts readily determined by a skilled clinical chemist. Representative amounts are illustrated in the examples below. It is critical in the practice of this invention that the creatine amidinohydrolase and leuco dye are present in a manner such that the enzyme is substantially inert to the dye. This means that the two reagents are incorporated in the element in such a manner that the enzyme does not adversely affect the leuco dye. This can be accomplished in a number of ways. For example, the enzyme can be used in a highly pure form so that the leuco dye is not affected by any impurities. More practically, however, the enzyme cannot be obtained in a highly pure form. In such cases, wither or both the enzyme and dye can be encapsulated or otherwise isolated from each other in the element until the assay is carried out. Preferably, the enzyme and leuco dye are located in different zones or layers of the element so that they do not mix until the time of the assay. A variety of different elements, depending on the method of assay, can be prepared in accordance with the present invention. Elements can be configured in a variety of forms, including elongated tapes of any desired width, sheets, slides or chips. The assay of this invention can be manual or automated. In general, in using the dry elements, creatinine or creatine determination is made by taking the element from a supply roll, chip packet or other source and physically contacting it with a sample (for example 1 to 200 µl) of the liquid to be tested so that the sample and reagents within the element become mixed. Such contact can be accomplished in any suitable manner, for example by dipping or immersing the element into the sample or, preferably, by spotting the element by hand or machine with a drop of the sample with a suitable dispensing means. After sample application, the element is exposed to any conditioning, such as incubation, heating or the like, that may be desirable to quicken or otherwise facilitate obtaining any test result. The rate of dye formation is then measured with suitable reflection or transmission spectrophotometric equipment and procedures. Generally, for creatine determination, a dye measurement is made prior to substantial conversion of creatinine, that is, soon after sample-element contact, for example, prior to 1 minute after sample-element contact. This measurement determines endogenous creatine because the rate limiting amount of creatinine amidohydrolase in the element has converted substantially no creatinine to creatine at this point. For creatinine determination, at least two dye measurements are made after substantially all endogenous creatine has been converted enzymatically to reaction products. Generally, the first measurement is made at least 4 minutes after sample-element contact. Another measurement is made thereafter in order to determine the rate of dye formation, and hence, the amount of creatinine. This sequence of measurements allows the use of the present element to measure either or both creatinine and creatine. Example 1 ; Assays for Creatine and Creatinine This example illustrates the practice of this invention for the determination of creatinine. This assay was carried out with the element having the following components: This element was used to simultaneously determine creatine and creatinine in the following manner. Separate calibration curves were prepared for creatine and creatinine by applying 10 µl samples of the appropriate calibrator fluids to separate elements, incubating and measuring the resulting dye at 670 nm. Reflectance density (D R ) readings were made at 60, 236 and 309 seconds after addition of each sample. The readings made at 60 seconds were used to plot a calibration curve for creatine. This curve enables one to determine creatine in a test sample when the dye measurement is made early in the assay. A calibration curve for creatinine was similarly obtained by subtracting the reading at 236 seconds from the respective reading taken at 309 seconds and dividing by 1.217 for each calibrator sample. This curve enables one to determine the kinetic rate of reaction for creatinine. Creatine and creatinine were then measured in test samples containing unknown amounts of these analytes by applying a sample of the test fluid to an element of this invention, reading the reflectance densities at the appropriate times and determining the respective analyte concentration from the appropriate calibration curve. FIG. 1 shows a plot of creatine values determined according to this invention vs. creatine values determined with a reference method. FIG. 2 is a plot of creatinine values for a number of test samples determined according to this invention vs. the creatinine values determined according to a reference method. These FIGS. show that the element of the present invention can be used to rapidly and accurately measure either creatinine or creatine or both.

Claims: 1. An analytical element for the determination of either creatinine or creatine comprising an absorbent carrier material containing creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase, the element characterized as further comprising an imidazole leuco dye which is capable of providing a detectable dye in the presence of hydrogen peroxide and a peroxidative substance, the creatine amidinohydrolase being present in a manner such that it is substantially inert to the leuco dye, and the creatinine amidohydrolase being present in a rate limiting amount. 2. The element as claimed in claim 1 wherein the creatine amidinohydrolase and leuco dye are physically located in separate zones of the element. 3. The element as claimed in either of claims 1 and 2 further comprising a peroxidative substance. 4. A multilayer analytical element for the determination of either creatinine or creatine comprising a support having thereon, in order, a first reagent layer containing sarcosine oxidase, creatinine amidohydrolase and a peroxidative substance, a second reagent layer containing creatine amidinohydrolase, and a porous spreading layer, the element characterized wherein the creatinine amidohydrolase is present in a rate limiting amount of the first reagent layer further comprises an imidazole leuco dye which is capable of providing a detectable dye in the presence of the peroxidative substance and hydrogen peroxide. 5. The element as claimed in any of claims 1 to 4 wherein the creatine amidinohydrolase and creatinine amidohydrolase are present in an activity coverage ratio of at least 50:1. 6. The element as claimed in any of claims 1 to 5 wherein the leuco dye is a triarylimidazole leuco dye. 7. A method for the determination of either creatinine or creatine comprising the steps of: A. in the presence of a peroxidative substance and a substance capable of providing a detectable dye in the presence of the peroxidative substance and hydrogen peroxide, contacting a sample of a liquid suspected of containing either creatinine or creatine with an analytical element comprising an absorbent carrier material containing creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase, and B. determining the detectable dye formed as a result of the presence of either creatinine or creatine, the method characterized wherein the element further comprises an imidazole leuco dye as the detectable dye providing substance, the creatine amidinohydrolase is present in a manner such that it is substantially inert to the leuco dye, and the creatinine amidohydrolase is present in a rate limiting amount. 8. The method as claimed in claim 7 for the kinetic determination of creatinine wherein the detectable dye is measured at least twice after substantially all endogenous creatine has been converted to reaction products after the contacting step. 9. The method as claimed in claim 7 for the determination of creatine wherein the detectable dye is measured prior to substantial conversion of endogenous creatinine after the contacting step. 10. The method as claimed in any of claims 7 to 9 wherein the liquid is human serum or urine.

Inventors: MAUCK, JOHN CHARLES C/O EASTMAN KODAK COMPANY, MAUCK, LINDA ANN C/O EASTMAN KODAK COMPANY, NORTON, GARY EDWARD C/O EASTMAN KODAK COMPANY
Applicants: EASTMAN KODAK COMPANY (A NEW JERSEY CORPORATION)
Application year: 1987
Main classification: G01N33
IPC codes: C12Q1, G01N33